 |
|
Misdiagnosis of Multidrug-Resistant Tuberculosis Possibly Due to Laboratory-Related Errors
Annette Tsugie Nitta, MD;
Paul Titus Davidson, MD;
Muriel Lucille de Koning, RN;
Robert Joseph Kilman
JAMA. 1996;276(24):1980-1983.
Abstract
| |
Objective.
—To describe 9 cases where a misdiagnosis of multidrug-resistant tuberculosis (MDR TB) was made, possibly due to laboratory-related errors.
Design.
—Case series.
Setting.
—Public and private hospitals, outpatient clinics, and mycobacteriology laboratories serving those institutions in Los Angeles County, Calif.
Patients.
—Consecutive sample of 70 patients diagnosed with MDR TB who were identified between August 1993 and August 1994 by the Multidrug-Resistant Unit within TB Control in Los Angeles County.
Outcome Measure.
—Detection of laboratory-related diagnostic errors.
Results.
—Pulmonary MDR TB was misdiagnosed in 9 (13%) of 70 patients. Reasons why the diagnoses appeared to be erroneous are as follows: growth of MDR TB from an old tuberculous lesion in a patient who was never treated for TB and whose diagnosis predated anti-TB drugs (1 case), documented contamination with Mycobacterium avium complex (1 case), suspected cross-contamination (1 case), suspected specimen mislabeling (1 case), successful treatment using drugs to which the isolate was reportedly resistant (4 cases), discrepant susceptibility test results on additional sputum specimens submitted by the patient (2 cases), and no clinical evidence of TB (3 cases).
Conclusions.
—These cases emphasize the diagnostic errors that can occur if mycobacterial susceptibility results are not correlated with all clinical data including other laboratory results for a given patient. We conclude that susceptibility results alone are not enough to dictate treatment, and that careful clinical correlation is necessary in making the diagnosis of MDR TB.
Author Affiliations
From Tuberculosis Control, Los Angeles County Department of Health Services, Public Health Programs and Services, Los Angeles, Calif (Drs Nitta and Davidson and Ms de Koning); Department of Medicine, Harbor-UCLA Medical Center, UCLA School of Medicine, Los Angeles (Dr Nitta); Department of Medicine, University of Southern California, Los Angeles (Dr Davidson); and the Public Health Laboratory, Los Angeles Department of Health Services, Public Health Programs and Services (Mr Kilman).
Footnotes
Presented in poster form at the American Thoracic Society Meeting, Seattle, Wash, May 20-24, 1995.
Corresponding author: Annette T. Nitta, MD, TB Control, 2615 S Grand Ave, Room 507, Los Angeles, CA 90007.
Toward Optimal Laboratory Use section editor: George D. Lundberg, MD, Editor, JAMA.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
False-Positive Mycobacterium tuberculosis Cultures in 44 Laboratories in The Netherlands (1993 to 2000): Incidence, Risk Factors, and Consequences
de Boer et al.
J. Clin. Microbiol. 2002;40:4004-4009.
ABSTRACT
| FULL TEXT
Estimation of the Rate of Unrecognized Cross-Contamination with Mycobacterium tuberculosis in London Microbiology Laboratories
Ruddy et al.
J. Clin. Microbiol. 2002;40:4100-4104.
ABSTRACT
| FULL TEXT
Limited Transmission of Multidrug-Resistant Tuberculosis Despite a High Proportion of Infectious Cases in Los Angeles County, California
NITTA et al.
Am. J. Respir. Crit. Care Med. 2002;165:812-817.
ABSTRACT
| FULL TEXT
An Outbreak of Bronchoscopy-Related Mycobacterium tuberculosis Infections Due to Lack of Bronchoscope Leak Testing
Ramsey et al.
Chest 2002;121:976-981.
ABSTRACT
| FULL TEXT
Laboratory Errors and the Misdiagnosis of Tuberculosis
Kaye et al.
JAMA 1997;277:882-882.
ABSTRACT
DRUG RESISTANCE IN TUBERCULOSIS IS OCCASIONALLY SPURIOUS
JWatch General 1997;1997:3-3.
FULL TEXT
|
